Mean | Treatment effect (RTM adjusted) | Standardised effecta (RTM adjusted) | p-value | |
---|---|---|---|---|
End of treatment | ||||
Emotional distress | 11.3 | −5.9 (−6.1 to −5.8) | −1.00 (−1.02 to −0.97) | <.0001 |
Cognitive distress | 8.0 | −4.3 (−4.4 to −4.2) | −1.03 (−1.06 to −1.00) | <.0001 |
Intrusiveness | 9.8 | −3.7 (−3.8 to −3.6) | −0.98 (−1.01 to −0.96) | <.0001 |
Auditory perceptual difficulties | 5.8 | −2.4 (−2.5 to −2.3) | −0.61 (−0.63 to −0.59) | <.0001 |
Sleep disturbances | 2.8 | −1.1 (−1.2 to −1.0) | −0.41 (−0.43 to −0.38) | <.0001 |
Somatic complaints | 1.9 | −0.7 (−0.8 to −0.6) | −0.31 (−0.34 to −0.28) | <.0001 |
Follow-up | ||||
Emotional distress | 11.3 | −4.2 (−5.2 to −2.3) | −0.67 (−0.96 to −0.39) | <.0001 |
Cognitive distress | 8.0 | −2.5 (−7.9 to +2.9) | −0.60 (−1.90 to +0.70) | 0.1126 |
Intrusiveness | 9.8 | −3.4 (−4.1 to −2.7) | −0.90 (−1.09 to −0.72) | <.0001 |
Auditory perceptual difficulties | 5.8 | −0.1 (−2.2 to +2.1) | −0.03 (−0.56 to +0.53) | 0.9273 |
Sleep disturbances | 2.8 | −0.9 (−2.0 to +0.2) | −0.33 (−0.72 to +0.07) | 0.0702 |
Somatic complaints | 1.9 | −0.4 (−2.8 to +2.0) | −0.17 (−1.27 to +0.94) | 0.4013 |